✅ Product Introduction:
Perigard-D 2/0.6 Mg Tablet contains Darifenacin (2 mg) and Dutasteride (0.6 mg). Darifenacin is an antimuscarinic agent that reduces urinary urgency and frequency, while Dutasteride is a 5-alpha-reductase inhibitor that helps shrink an enlarged prostate gland. Together, they are used to manage urinary symptoms in men with BPH and bladder overactivity.
✅ Uses:
-
Benign Prostatic Hyperplasia (BPH)
-
Overactive bladder symptoms
-
Difficulty or discomfort in urination
-
Frequent and urgent urination
✅ Benefits:
-
Improves bladder control
-
Reduces urinary urgency and frequency
-
Shrinks the prostate to improve urine flow
-
Prevents disease progression and need for surgery
✅ Composition:
-
Darifenacin 2 mg
-
Dutasteride 0.6 mg
✅ Side Effects:
-
Dry mouth
-
Constipation
-
Dizziness
-
Decreased libido or erectile dysfunction
-
Headache
-
Breast tenderness (in men, rare)
Note: Side effects are typically mild. Consult your doctor if they persist or worsen.
✅ Safety Advice:
-
Swallow whole with a glass of water; do not crush or chew
-
Take at the same time daily
-
Not for use in women or children
-
Pregnant women should avoid handling the tablet
-
Avoid alcohol and driving until you know how it affects you
-
Regular prostate check-ups and PSA monitoring are recommended
-
Store in a cool, dry place away from direct light
